Short-term morbidity from CT-planned transperineal I-125 prostate implants Journal Article


Authors: Arterbery, V. E.; Wallner, K.; Roy, J.; Fuks, Z.
Article Title: Short-term morbidity from CT-planned transperineal I-125 prostate implants
Abstract: Purpose: To summarize short-term morbidity and tumor response following transperineal transperineal CT-guided I-125 prostate implantation. Methods and Materials: Twenty-one patients were treated with CT-based transperineal 1-125 prostate implantation between June, 1988 and May, 1990. An average of 75 I-125 seeds were placed, with an average activity of .62 mCi/seed. Symptoms were quantified after interviewing each patient in detail. Results: Nearly all patients developed substantial dysuria, nocturia and frequency from 2-24 weeks following implantation. Urinary symptoms usually resolved within 4-6 months of implantation. The one year actuarial potency rate among 18 patients who were potent prior to implantation was 94%. By 6 months after implantation, 14 17 patients (82%) with Stage B tumors had complete regression of palpable disease. Of 17 patients with Stage A or B tumors who presented with an elevated PSA, 76% returned to the normal range within 6 months of implantation. Conclusion: CT-guided transperineal prostate implants entail moderate, temporary urinary and rectral morbidity. Short-term tumor responses are encouraging. © 1993.
Keywords: clinical article; diarrhea; follow-up studies; neoplasm staging; prostate specific antigen; computer assisted tomography; morbidity; tomography, x-ray computed; radiation injury; time factors; prostatic neoplasms; cancer regression; iodine 125; brachytherapy; impotence; computed tomography; dysuria; prostate carcinoma; rectum hemorrhage; ejaculation; proctitis; nocturia; iodine-125; urination disorders; terazosin; prostatic carcinoma; phenazopyridine; human; male; priority journal; article; rectum ulcer; support, non-u.s. gov't
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 25
Issue: 4
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 1993-03-15
Start Page: 661
End Page: 667
Language: English
DOI: 10.1016/0360-3016(93)90013-l
PUBMED: 8454484
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 March 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Zvi Fuks
    427 Fuks
  2. Kent E. Wallner
    48 Wallner
  3. Jitendra N. Roy
    18 Roy